Mannavola Cataldo Maria, De Maio Flavio, Marra John, Fiori Barbara, Santarelli Giulia, Posteraro Brunella, Sica Simona, D'Inzeo Tiziana, Sanguinetti Maurizio
Department of Basic Biotechnological Sciences, Intensive and Perioperative Clinics, Università Cattolica del Sacro Cuore, Rome, Italy.
Department of Laboratory and Hematological Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Gut Pathog. 2025 Jun 21;17(1):47. doi: 10.1186/s13099-025-00722-3.
Bloodstream infections (BSIs) pose a persistent threat to hospitalized patients, particularly those who are immunocompromised and susceptible to infections caused by anaerobic or facultative anaerobic bacteria. Alterations in gut microbiota composition can predispose individuals to intestinal domination by one or more pathobionts, increasing the risk of bacterial translocation into the bloodstream and subsequent bacteremia.
We report the case of a 20-year-old female with multiple relapsed/refractory Philadelphia-negative B-cell acute lymphoblastic leukemia, initially referred to our hematology center for CAR-T cell therapy. The patient ultimately underwent allogeneic hematopoietic stem cell transplantation, which was complicated by infections, moderate-to-severe graft-versus-host disease, hepatic sinusoidal obstruction syndrome, and transplant-associated thrombotic microangiopathy, all contributing to a fatal outcome. Blood cultures obtained in the final week before the patient succumbed to multi-organ toxicity grew . A fecal sample collected concurrently for intestinal microbiota characterization revealed a marked predominance of (98.5%), with dominating at 47.9%, followed by (18.59%) and Staphylococcus (3.5%) at the genus level. We performed genomic comparison between the isolated from blood cultures and the best-matched strain detected in the intestinal microbiota.
We report the isolation of from blood cultures in a patient post hematopoietic cell transplantation, with genomic similarity to a gut-dominant strain. This case highlights the potential link between intestinal domination and subsequent bloodstream infection, supporting the value of gut microbiota profiling as an adjunctive tool for monitoring high-risk patients, such as hematopoietic cell transplant recipients.
The online version contains supplementary material available at 10.1186/s13099-025-00722-3.
血流感染(BSIs)对住院患者构成持续威胁,尤其是那些免疫功能低下且易受厌氧或兼性厌氧细菌感染的患者。肠道微生物群组成的改变会使个体易受一种或多种致病共生菌在肠道内占主导地位,增加细菌易位进入血液并引发随后菌血症的风险。
我们报告了一名20岁女性的病例,她患有多次复发/难治性费城阴性B细胞急性淋巴细胞白血病,最初转诊至我们的血液学中心接受嵌合抗原受体T细胞(CAR-T)治疗。该患者最终接受了异基因造血干细胞移植,出现了感染、中重度移植物抗宿主病、肝窦阻塞综合征和移植相关血栓性微血管病等并发症,所有这些都导致了致命的结局。在患者死于多器官毒性前最后一周采集的血培养物中培养出了[具体细菌名称未给出]。同时采集的用于肠道微生物群特征分析的粪便样本显示,在属水平上,[具体细菌名称未给出]占绝对优势(98.5%),其中[另一具体细菌名称未给出]占47.9%,其次是[又一具体细菌名称未给出](18.59%)和葡萄球菌(3.5%)。我们对从血培养物中分离出的[具体细菌名称未给出]与在肠道微生物群中检测到的最匹配菌株进行了基因组比较。
我们报告了在一名造血细胞移植后的患者血培养物中分离出[具体细菌名称未给出],其与肠道优势[具体细菌名称未给出]菌株具有基因组相似性。该病例突出了肠道占主导地位与随后血流感染之间的潜在联系,支持了肠道微生物群分析作为监测高危患者(如造血细胞移植受者)的辅助工具的价值。
在线版本包含可在10.1186/s13099-025-00722-3获取的补充材料。